K. Fearon
Surgery · 2005–2018
A researcher in the Science corpus: 16 papers; trusts 4 researchers and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Surgery — 116 citations into it; #1,011 of 1,106 by trust here, #251 by citations
- Physiology — 103 citations into it; #1,606 of 2,276 by trust here, #490 by citations
- Molecular Biology — 58 citations into it
Whom K. Fearon trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts K. Fearon overall
Papers from K. Fearon's perspective
Ordered by how strongly the researchers K. Fearon trusts endorse each paper. Same corpus, a different order for every researcher.
- Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy (Proceedings of the National Academy of Sciences of the United States of America)
- FoxO3 controls autophagy in skeletal muscle in vivo. (Cell Metabolism)
- Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy (Science)
- Myostatin mutation associated with gross muscle hypertrophy in a child. (New England Journal of Medicine)
- Autophagy in metazoans: cell survival in the land of plenty (Nature reviews. Molecular cell biology)
- PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription (Proceedings of the National Academy of Sciences of the United States of America)
- Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. (Nature)
- Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size. (American Journal of Physiology - Cell Physiology)
- FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. (Cell Metabolism)
- Anaesthesia, surgery, and challenges in postoperative recovery. (The Lancet)
Their papers
- Understanding the mechanisms and treatment options in cancer cachexia (2013) — 868 citations
- Cancer cachexia: mediators, signaling, and metabolic pathways. (2012) — 1,139 citations
- Cancer-associated cachexia (2018) — 1,431 citations
- ESPEN guidelines on nutrition in cancer patients. (2017) — 2,628 citations
- Enhanced Recovery After Surgery: A Review (2017) — 3,229 citations
- Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for anaesthesia practice (2015) — 653 citations
- The Impact of Enhanced Recovery Protocol Compliance on Elective Colorectal Cancer Resection: Results From an International Registry. (2015) — 597 citations
- Guidelines for Perioperative Care in Elective Colonic Surgery: Enhanced Recovery After Surgery (ERAS®) Society Recommendations (2012) — 1,958 citations
- Definition and classification of cancer cachexia: an international consensus. (2011) — 4,957 citations
- The enhanced recovery after surgery (ERAS) pathway for patients undergoing major elective open colorectal surgery: a meta-analysis of randomized controlled trials. (2010) — 1,153 citations
- Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) "cachexia-anorexia in chronic wasting diseases" and "nutrition in geriatrics". (2010) — 1,618 citations
- Consensus review of optimal perioperative care in colorectal surgery: Enhanced Recovery After Surgery (ERAS) Group recommendations. (2009) — 1,131 citations
- ESPEN Guidelines on Parenteral Nutrition: surgery. (2009) — 668 citations
- Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer (2009) — 632 citations
- Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. (2006) — 731 citations
- Enhanced recovery after surgery: a consensus review of clinical care for patients undergoing colonic resection. (2005) — 1,632 citations